Dr. Sulaiman Al Habib
سليمان الحبيبTechnical Analysis & Signals
Sulaiman Al Habib's stock is trading in a downtrend with clear negative signals.
Technical Analysis
The stock shows a downtrend with a Relative Strength Index (RSI) dropping to 36.0, indicating weakness in momentum. Additionally, the negative crossover in the MACD reinforces the likelihood of continued bearish movement.
Support & Resistance Levels
The key support level is at 214.03 SAR, while resistance is at 228.1 SAR. The stock is likely to test the support level if selling pressure continues.
Volume Analysis
Trading volume may indicate a decline in interest in the stock, reflecting weakness in the current trend. Volume is expected to increase if a breakout occurs above the resistance level.
Fundamental Factors
The price-to-earnings (P/E) ratio stands at 33.5, indicating a relatively high valuation. The dividend yield at 1.77% may attract some investors, but the current technical performance could negatively impact confidence.
Risk Factors
Key risks include the continuation of the downtrend, which could lead to further price declines. Additionally, fluctuations in the Saudi market and the TASI index may impact the stock's performance.
Recommendation
Disclaimer: This analysis is for educational purposes only and does not constitute investment advice. Selling pressure is expected to continue, so investors should closely monitor developments.
Automated analysis is based on historical data and technical indicators and may not reflect future market conditions.
Financial Fundamentals
Price Data
Price Chart - Dr. Sulaiman Al Habib
4013Technical Analysis
Moving Averages
Momentum Indicators
Bollinger Bands
Within BandTrend Strength (ADX)
Moderate TrendFinancial Summary
Valuation
- Market Cap
- 78.61B
- P/E Ratio
- 33.50
- P/B Ratio
- 9.90
- EPS (Earnings/Share)
- 6.71
Profitability
- Revenue
- 13.98B
- Net Income
- 2.35B
- Return on Equity (ROE)
- +30.00%
- Shares Outstanding
- 350.00M
Balance Sheet
- Total Assets
- N/A
- Total Debt
- 9.50B
- Debt/Equity
- 1.12
- Free Float %
- +29.1%
Dividends & Margins
- Dividend Yield
- +1.77%
- Dividend/Share
- 4.04
- Book Value
- 22.69
Financial data extracted from published quarterly reports. All values in SAR unless otherwise stated.
Historical Financial Data
5 years| Year | Revenue | Net Income | Total Assets | Total Debt | EPS |
|---|---|---|---|---|---|
| 2025 | 13.71B +22.4% | 2.40B +3.7% | 23.20B +12.9% | 9.30B +14.0% | 6.86 +3.6% |
| 2024 | 11.20B +17.8% | 2.32B +13.2% | 20.56B +30.1% | 8.17B +57.5% | 6.62 +13.2% |
| 2023 | 9.51B +14.4% | 2.05B +23.9% | 15.80B +25.5% | 5.18B +47.2% | 5.85 +23.9% |
| 2022 | 8.31B | 1.65B | 12.58B | 3.52B | 4.72 |
| 2021 | — | — | — | — | — |
Historical data sourced from Yahoo Finance and may differ from official audited financial reports.
Price Forecast
These forecasts are based on technical analysis and AI and do not constitute investment advice. Past performance does not guarantee future results.
News & Events
Sulaiman Al Habib opens new medical centre in Riyadh
SNB Capital: TASI likely to trade between 10,000-11,700 pts in 2026
Sulaiman Al Habib to build 2 hospitals worth SAR 2B in Dammam, Riyadh
BSF Capital sets recommendation, TP for Sulaiman Al Habib
ANB Capital reviews Q4 2025 financials of four healthcare firms
Analysts weigh in on Sulaiman Al Habib Q4 2025 results
Sulaiman Al Habib Q4 2025: Financials, operating segment performance
Firms likely to declare cash dividends in Feb. based on historical pattern
News source: Argaam (argaam.com)
Sector Comparison
| Symbol | Name | Price | Change% |
|---|---|---|---|
| 4013 | Dr. Sulaiman Al Habib | 224.60 SAR | |
| 4002 | Mouwasat | 66.50 SAR | |
| 4004 | Dallah Healthcare | 112.00 SAR | |
| 4017 | Fakeeh Care | 36.00 SAR | |
| 4018 | Almoosa | 129.50 SAR | |
| 4005 | CARE | 103.30 SAR | |
| 4019 | SMC Healthcare | 17.60 SAR | |
| 4007 | Alhammadi | 25.32 SAR |
Dividend History
Dividend data from Tadawul records. All amounts in SAR. Estimated yield calculated based on year-end price.
Ownership Structure
Data source: Yahoo FinanceLast updated: 2026-05-11
Risk Assessment
Risk Factors
Average True Range 2.1% of stock price
Trading volume near or above average
P/E ratio 33.5 — above average
Debt-to-equity ratio 1.12
ADX indicator at 33
High volatility and financial pressures requiring careful monitoring
This assessment is automated based on quantitative data and does not constitute investment advice. Please consult a licensed financial advisor before making investment decisions.
FAQ
1 What is Dr. Sulaiman Al Habib stock price today?
Dr. Sulaiman Al Habib (4013) stock price today is 224.60 SAR, declining by -1.53% compared to the previous session close. The 52-week price range is between 214.03 SAR and 277.18 SAR.
2 What is Dr. Sulaiman Al Habib stock valuation?
The automated analysis signal for Dr. Sulaiman Al Habib is "Sell" with 70% confidence. The P/E ratio is 33.5. The P/B ratio is 9.90.
3 Is Dr. Sulaiman Al Habib Shariah-compliant?
Yes, Dr. Sulaiman Al Habib (4013) is Shariah-compliant according to the latest lists approved by relevant Shariah authorities.
4 What are Dr. Sulaiman Al Habib dividend distributions?
Dr. Sulaiman Al Habib has a dividend yield of 1.77%, with an estimated annual dividend of 4.04 SAR per share.
5 What is Dr. Sulaiman Al Habib weekly performance?
Dr. Sulaiman Al Habib performance over different time periods: weekly change -2.75%, monthly -9.75%, and year-to-date -11.73%. The stock is currently trading with a volume of 273,765 shares.
6 What is the target level for Dr. Sulaiman Al Habib?
According to automated analysis for Dr. Sulaiman Al Habib: Short-term target (1-2 weeks): 220.00 SAR. Medium-term target (1-3 months): 210.00 SAR. Support level: 214.03 SAR. Resistance level: 228.10 SAR. Note: These are automated analytical levels and do not constitute investment advice.
Disclaimer
The information provided on this page is for educational and analytical purposes only and does not constitute investment advice or a recommendation to buy or sell. Past performance does not guarantee future results. All investments involve risk including loss of capital. Please consult a licensed financial advisor before making any investment decisions.
Automated analysis relies on historical data and technical indicators and may not reflect future market conditions.